apollo
logo
0Login

Formoterol Fumarate+glycopyrronium

About Formoterol Fumarate+glycopyrronium

Formoterol Fumarate+glycopyrronium belongs to the group of medicines called bronchodilators indicated for long-term, maintenance treatment of Chronic Obstructive Pulmonary Disease (COPD). COPD is a group of lung diseases with emphysema (shortness of breath) and chronic bronchitis (inflammation of the bronchial tube lining). In COPD, the muscles around the airways tighten, making it difficult to breathe.
 
Formoterol Fumarate+glycopyrronium is a combination of two medicines, namely: Formoterol fumarate (long-acting beta2-adrenergic agonist) and Glycopyrronium (anti-cholinergic). Formoterol fumarate prevents tightening of the muscles in the airways, making it easier for the air to get in and out of the lungs. Glycopyrronium decreases the secretions in the airways. Together, Formoterol Fumarate+glycopyrronium provides relief from COPD.
 
You are advised to use Formoterol Fumarate+glycopyrronium for as long as your doctor has prescribed it for you, depending on your medical condition. In some cases, you may experience common side-effects such as headache, nausea, dry mouth, chest pain, muscle cramps, dizziness, painful and frequent urination. Most of these side effects do not require medical attention and will resolve gradually over time. However, you are advised to talk to your doctor if the side effects persist or worsen.
 
Do not stop taking Formoterol Fumarate+glycopyrronium on your own as it might cause worsening of symptoms. Consult your doctor if you are pregnant or breastfeeding. Formoterol Fumarate+glycopyrronium may cause dizziness, so drive with caution. Avoid consuming alcohol as it might cause increased dizziness. Formoterol Fumarate+glycopyrronium is not recommended for children below 18 years as safety and effectiveness have not been established. Keep your doctor informed about your health condition and the medicines you are taking to avoid unpleasant side effects.

Uses of Formoterol Fumarate+glycopyrronium

Chronic Obstructive Pulmonary Disease (COPD).

Medicinal Benefits

Formoterol Fumarate+glycopyrronium is a combination of two medicines, namely: Formoterol fumarate and Glycopyrronium. Formoterol Fumarate+glycopyrronium belongs to the group of medicines called bronchodilators used to treat Chronic Obstructive Pulmonary Disease (COPD). Formoterol fumarate is a long-acting beta-agonist that prevents the tightening of the muscles in the airways, making it easier for the air to get in and out of the lungs. Glycopyrronium is an anti-cholinergic that decreases the secretions in the airways. Together, Formoterol Fumarate+glycopyrronium provides relief from COPD.

Directions for Use

Capsule/Respicap/Rotacap: It is meant for inhalation only; do not swallow the capsule/respicap/rotacap. Place it at the base of the rotahaler/inhaler/respihaler and twist the mouthpiece until you hear a click sound. Breath in deeply through the mouthpiece and hold up your breath for 10 seconds. Inhaler: Hold the inhaler with the mouthpiece downwards. Place your lips on the mouthpiece and press down on the inhaler once to release the medication. Breath in slowly and repeat the process until you have inhaled the number of puffs prescribed by the doctor.

Storage

Store in a cool and dry place away from sunlight

Side Effects of Formoterol Fumarate+glycopyrronium

  • Headache
  • Dizziness
  • Dry mouth
  • Nausea
  • Painful and frequent urination
  • Chest pain
  • Muscle cramps

Patients Concern

Disease/Condition Glossary

Chronic Obstructive Pulmonary Disease (COPD): It is a group of lung diseases with emphysema (shortness of breath) and chronic bronchitis (inflammation of the lining of bronchial tubes). The major cause of COPD is smoking tobacco. Also, long-term exposure to fumes and chemicals may lead to COPD. The symptoms include chronic cough, shortness of breath or wheezing (whistle sound while breathing).

FAQs

Formoterol Fumarate+glycopyrronium contains Formoterol fumarate and Glycopyrronium. Formoterol fumarate relaxes and widens the openings in the airways, making it easier for the air to get in and out of the lungs. Glycopyrronium decreases the secretions in the airways. Together, Formoterol Fumarate+glycopyrronium provides relief from COPD.

Formoterol Fumarate+glycopyrronium is indicated for the maintenance treatment for COPD. It does not treat a sudden attack of wheezing or breathlessness. Use a rescue inhaler to treat sudden breathing problems.

Dry mouth could be a side-effect of Formoterol Fumarate+glycopyrronium. Limiting caffeine intake, avoiding smoking and mouthwashes containing alcohol, drinking water regularly.

Do not stop using Formoterol Fumarate+glycopyrronium on your own as it might cause worsening of symptoms. To treat your condition effectually, continue using Formoterol Fumarate+glycopyrronium for as long as your doctor has prescribed it. Talk to your doctor if your breathing problems, wheezing, or cough do not improve or worsen.

No, Formoterol Fumarate+glycopyrronium is not indicated for the treatment of asthma as the safety and effectiveness of Formoterol Fumarate+glycopyrronium in patients with asthma have not been established. Consult your doctor if you have asthma.

Consult your doctor if you are diabetic as it might sometimes raise blood sugar levels. Regular monitoring of blood glucose levels whilst taking Formoterol Fumarate+glycopyrronium is advised.

Available Medicines for

Formoterol Fumarate+glycopyrronium

VIEW MORE PRODUCTS